PVRV + PVRV and pERIG Favirab® + PVRV and pERIG Favirab®
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Rabies
Conditions
Rabies
Trial Timeline
Jun 29, 2012 → Nov 14, 2018
NCT ID
NCT01622062About PVRV + PVRV and pERIG Favirab® + PVRV and pERIG Favirab®
PVRV + PVRV and pERIG Favirab® + PVRV and pERIG Favirab® is a phase 3 stage product being developed by Sanofi for Rabies. The current trial status is completed. This product is registered under clinical trial identifier NCT01622062. Target conditions include Rabies.
What happened to similar drugs?
2 of 14 similar drugs in Rabies were approved
Approved (2) Terminated (0) Active (12)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01622062 | Phase 3 | Completed |
Competing Products
20 competing products in Rabies